Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Patupilone trial for patients with recurrent glioblastoma, which are planned for
re-operation. Objectives: prolongation of PFS compared to patients with re-operation only,
Patupilone tumor concentrations, pharmacokinetic, Perfusion in MRI pre - and post Patupilone.
Translational research of tumor tissue exposed to patupilone.
- Trial with medicinal product